Management of Medication-Induced Psychiatric Disorders

Overview

Journal Indian J Psychiatry

Specialty Psychiatry

Date 2022 May 23

PMID 35602361

Authors

N N Raju

K S V R Naga Pavan Kumar

Gyan Nihal

Affiliations

Soon will be listed here.

Citing Articles

The effect of dexamethasone on the prevalence of delirium in older COVID-19 patients: a retrospective cohort study.

van der Laan C, Goossens K, Robben S, Kappers M Eur Geriatr Med. 2025; .

PMID: 39969802 DOI: 10.1007/s41999-024-01033-7.

Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives.

Yadav V, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R Front Med (Lausanne). 2025; 12:1535682.

PMID: 39911864 PMC: 11794224. DOI: 10.3389/fmed.2025.1535682.

Molecular, Pathophysiological, and Clinical Aspects of Corticosteroid-Induced Neuropsychiatric Effects: From Bench to Bedside.

Sofia-Avendano-Lopez S, Rodriguez-Marin A, Lara-Castillo M, Agresott-Carrillo J, Lara-Cortes L, Sanchez-Almanzar J Biomedicines. 2024; 12(9).

PMID: 39335644 PMC: 11429036. DOI: 10.3390/biomedicines12092131.

References

Keime-Guibert F, Napolitano M, Delattre J . Neurological complications of radiotherapy and chemotherapy. J Neurol. 1998; 245(11):695-708. DOI: 10.1007/s004150050271. View

Konstam V, Moser D, De Jong M . Depression and anxiety in heart failure. J Card Fail. 2005; 11(6):455-63. DOI: 10.1016/j.cardfail.2005.03.006. View

Liu M, Huang Y, Hsu S, Kass J . Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs. 2016; 30(12):1149-1168. DOI: 10.1007/s40263-016-0392-x. View

Valipour G, Saneei P, Esmaillzadeh A . Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014; 99(10):3863-72. DOI: 10.1210/jc.2014-1887. View

Huffman J, Stern T . Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007; 9(1):29-45. PMC: 3181843. View

Cantu T, Korek J . Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med. 1991; 114(12):1027-34. DOI: 10.7326/0003-4819-114-12-1027. View

Kass J, Shandera W . Nervous system effects of antituberculosis therapy. CNS Drugs. 2010; 24(8):655-67. DOI: 10.2165/11534340-000000000-00000. View

Cummings J . Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc. 1991; 39(7):708-16. DOI: 10.1111/j.1532-5415.1991.tb03627.x. View

Connerney I, Shapiro P, McLAUGHLIN J, Bagiella E, Sloan R . Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001; 358(9295):1766-71. DOI: 10.1016/S0140-6736(01)06803-9. View

10.

Bangert M, Hasbun R . Neurological and Psychiatric Adverse Effects of Antimicrobials. CNS Drugs. 2019; 33(8):727-753. DOI: 10.1007/s40263-019-00649-9. View

11.

Tango R . Psychiatric side effects of medications prescribed in internal medicine. Dialogues Clin Neurosci. 2011; 5(2):155-65. PMC: 3181628. View

12.

Holdiness M . Neurological manifestations and toxicities of the antituberculosis drugs. A review. Med Toxicol. 1987; 2(1):33-51. DOI: 10.1007/BF03259859. View

13.

English B, Dortch M, Ereshefsky L, Jhee S . Clinically significant psychotropic drug-drug interactions in the primary care setting. Curr Psychiatry Rep. 2012; 14(4):376-90. PMC: 4335312. DOI: 10.1007/s11920-012-0284-9. View

14.

Lotrich F, Rabinovitz M, Gironda P, Pollock B . Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res. 2007; 63(2):131-5. PMC: 2104514. DOI: 10.1016/j.jpsychores.2007.05.013. View

15.

DiMaggio J, Baile W . H2 blocker delirium. Psychosomatics. 1995; 36(1):74-7. DOI: 10.1016/S0033-3182(95)71712-1. View

16.

Smith D . Psychiatric side effects of non-psychiatric drugs. S D J Med. 1991; 44(10):291-2. View

17.

Dieperink E, Ho S, Thuras P, Willenbring M . A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003; 44(2):104-12. DOI: 10.1176/appi.psy.44.2.104. View

18.

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

19.

Kami M, Hamaki T, Kusumi E, Iwata H, Ueyama J, Morinaga S . Recurrent psychotic episodes in a patient who received rituximab for the treatment of non-Hodgkin's lymphoma. Hematol J. 2004; 5(1):90. DOI: 10.1038/sj.thj.6200305. View

20.

Warnock J, Bundren J, Morris D . Depressive symptoms associated with gonadotropin-releasing hormone agonists. Depress Anxiety. 1998; 7(4):171-7. DOI: 10.1002/(sici)1520-6394(1998)7:4<171::aid-da5>3.0.co;2-d. View